{
    "balance": {
        "data": [
            "CONSOLIDATED BALANCE SHEET\tDecember 31,\tDecember 31,\t(In millions except share and per share amounts)\t2021\t2020\tAssets\tCurrent assets:\tCash and cash equivalents\t$\t4,477\t$\t10,325\tAccounts receivable, less allowances of $\t150\tand $\t135\t7,977\t5,741\tInventories\t5,051\t4,029\tContract assets, net\t968\t731\tOther current assets\t1,640\t1,131\tTotal current assets\t20,113\t21,957\tProperty, plant and equipment, net\t8,333\t5,912\tAcquisition-related intangible assets, net\t20,113\t12,685\tOther assets\t4,640\t2,457\tGoodwill\t41,924\t26,041\tTotal assets\t$\t95,123\t$\t69,052\tLiabilities, redeemable noncontrolling interest and equity\tCurrent liabilities:\tShort-term obligations and current maturities of long-term obligations\t$\t2,537\t$\t2,628\tAccounts payable\t2,867\t2,175\tAccrued payroll and employee benefits\t2,427\t1,916\tContract liabilities\t2,655\t1,271\tOther accrued expenses\t2,950\t2,314\tTotal current liabilities\t13,436\t10,304\tDeferred income taxes\t3,837\t1,794\tOther long-term liabilities\t4,540\t3,330\tLong-term obligations\t32,333\t19,107\tCommitments and contingencies (Note 12)\tRedeemable noncontrolling interest\t122\t \tEquity:\tThermo Fisher Scientific Inc. shareholders  equity:\tPreferred stock, $\t100\tpar value,\t50,000\tshares authorized;\tnone\tissued\tCommon stock, $\t1\tpar value,\t1,200,000,000\tshares authorized;\t439,154,741\tand\t437,088,297\tshares issued\t439\t437\tCapital in excess of par value\t16,174\t15,579\tRetained earnings\t35,431\t28,116\tTreasury stock at cost,\t44,720,112\tand\t40,417,789\tshares\t(\t8,922\t)\t(\t6,818\t)\tAccumulated other comprehensive items\t(\t2,329\t)\t(\t2,807\t)\tTotal Thermo Fisher Scientific Inc. shareholders  equity\t40,793\t34,507\tNoncontrolling interests\t62\t10\tTotal equity\t40,855\t34,517\tTotal liabilities, redeemable noncontrolling interest and equity\t$\t95,123\t$\t69,052\tThe accompanying notes are an integral part of these consolidated financial statements.\tF-6\tTHERMO FISHER SCIENTIFIC INC.\tCONSOLIDATED STATEMENT OF INCOME\tYear Ended\tDecember 31,\tDecember 31,\tDecember 31,\t(In millions except per share amounts)\t2021\t2020\t2019\tRevenues\tProduct revenues\t$\t30,361\t$\t25,306\t$\t19,496\tService revenues\t8,850\t6,912\t6,046\tTotal revenues\t39,211\t32,218\t25,542\tCosts and operating expenses:\tCost of product revenues\t13,594\t11,407\t10,037\tCost of service revenues\t5,979\t4,807\t4,177\tSelling, general and administrative expenses\t8,007\t6,930\t6,144\tResearch and development expenses\t1,406\t1,181\t1,003\tRestructuring and other costs (income)\t197\t99\t(\t413\t)\tTotal costs and operating expenses\t29,183\t24,424\t20,948\tOperating income\t10,028\t7,794\t4,594\tInterest income\t43\t65\t224\tInterest expense\t(\t536\t)\t(\t553\t)\t(\t676\t)\tOther income/(expense)\t(\t694\t)\t(\t76\t)\t(\t70\t)\tIncome before income taxes\t8,841\t7,230\t4,072\tProvision for income taxes\t(\t1,109\t)\t(\t850\t)\t(\t374\t)\tEquity in (losses) earnings of unconsolidated entities\t(\t4\t)\t(\t3\t)\t \tNet income\t7,728\t6,377\t3,698\tLess: net income attributable to noncontrolling interests and redeemable noncontrolling interest\t3\t2\t2\tNet income attributable to Thermo Fisher Scientific Inc.\t$\t7,72"
        ],
        "timestamp": "2025-01-21_09-41-38"
    }
}